News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Delaware Court Denies Plaintiffs’ Request to Enjoin CVS Corporation/Caremark Rx Merger
February 26, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NASHVILLE, Tenn.--(BUSINESS WIRE)--Caremark Rx, Inc. (NYSE: CMX) today announced that the Delaware Court of Chancery has denied plaintiffs’ motion to enjoin Caremark’s planned merger with CVS Corporation (NYSE: CVS).
Twitter
LinkedIn
Facebook
Email
Print
Legal
Mergers & acquisitions
Regulatory
MORE ON THIS TOPIC
Drug pricing
Trump Administration Reaches Pricing Agreements with 9 More Drugmakers
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Policy
Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Business
BioSpace
Editors’ Top 5 Biggest News Stories of the Year
December 22, 2025
·
10 min read
·
Annalee Armstrong
Mergers & acquisitions
BioMarin Pumps Up Revenue Goals With $4.8B Amicus Purchase
December 19, 2025
·
2 min read
·
Dan Samorodnitsky
